Navigation Links
Countering fake and substandard drugs: IOM report releases Feb. 13
Date:2/13/2013

As the recent appearance of fake versions of cancer drugs illustrates, the increase in international production and trade of medications has come with an increase in illegitimate or poor-quality drugs reaching patients worldwide. Countering the Problem of Falsified and Substandard Drugs, a new report from the Institute of Medicine, recommends steps to improve the capacity of the United States and other nations to discover fake or subpar products and close gaps that allow products to be falsified or diluted.

The report will be released with a public briefing starting at 9:30 a.m. EST Wednesday, Feb. 13, in Room 120 of the National Academy of Sciences building, 2101 Constitution Ave., N.W., Washington, D.C. Seating is limited and advance registration is required. Those who cannot attend may watch a live webcast at http://www.iom.edu/fakedrugswebcast.


'/>"/>

Contact: Christine Stencel
news@nas.edu
202-334-2138
National Academy of Sciences
Source:Eurekalert

Page: 1

Related medicine news :

1. New technology represents next-generation tool for detecting substandard and counterfeit medicines
2. American Kids Getting Fewer Prescription Drugs: Study
3. More Pregnant Women on Blood Pressure Drugs: Study
4. Young girls more likely to report side effects after HPV vaccine
5. Preteens More Likely to Report HPV Vaccine Side Effects
6. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
7. Report says new evidence could tip the balance in aspirin cancer prevention care
8. U.S. Spends Too Little on Public Health Initiatives: Report
9. NJ stroke researchers report advances in spatial neglect research at AAN Conference
10. Mental Illness Tied to Higher Rates of Physical Problems: Report
11. Diagnostic yield of colonoscopy for melena after nondiagnostic upper endoscopy is lower than previously reported
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Penn Medicine team has found that targeted automated ... tract infections in hospital patients with urinary catheters. ... was simplified, the rate of improvement dramatically increased. ... patients need urinary catheters in the first place ... for catheters that have not been removed within ...
(Date:8/22/2014)... Natural Clear Vision , a how-to guide ... vision from legally blind to perfect 20/20 vision has caught ... , “There is a huge portion of the population today ... most people just think that’s the way it will always ... be pretty risky at times,” reports Michaels. “This program is ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in the ... advanced non-small cell lung cancer (NSCLC) patients correlates well ... , EGFR tyrosine kinase inhibitor (TKI) therapy is approved ... but the standard for determining mutation status is with ... limited or not available. A more abundant and less ...
(Date:8/22/2014)... York, New York (PRWEB) August 22, 2014 ... continue to be filed in U.S. courts on ... events due to their use of prescription low ... court documents, a new claim was filed against ... man who allegedly suffered life-threatening heart issues due ...
(Date:8/22/2014)... FRIDAY, Aug. 22, 2014 (HealthDay News) -- An intensive effort ... to an animal shelter in Florida and euthanized, a new ... enough cats to slow their intake into animal control," Dr. ... of Florida College of Veterinary Medicine, said in a university ... there wasn,t making a big impact," she explained, "so we ...
Breaking Medicine News(10 mins):Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Neutering Project Curbed Feral Cat Population 2
... Pharmacopeia,(Nasdaq: PCOP ), an innovator in ... today announced that it has licensed from,Bristol-Myers Squibb ... modulator,(SARM) program, including a lead compound in Phase ... non-steroidal selective androgen,receptor modulator, or SARM, which was ...
... Ill. A study published in the October ... (JCSM) finds that modafinil is well-tolerated in the treatment ... wakefulness such as shift work sleep disorder, obstructive sleep ... or sleep parameters. , The study, authored by Thomas ...
... 15 With school schedules now routine and,the initial ... again",sighs. This might be a good time to re-evaluate ... http://www.newscom.com/cgi-bin/prnh/20071015/NYFNSL01 ) The following are suggestions ... and snacks for greater nutritional impact. Add a,handful of ...
... - ,Real Women, Real Pain, Campaign Highlights ... in Women Around the World Today, the International ... the Global Year Against Pain in Women to draw ... and the need for more,effective care. Lack of awareness ...
... A new study by Rhode Island Hospital and Brown University ... surgery did not receive the initial psychiatric clearance for the ... of decisions to clear candidates for surgery, and the largest ... and detail the reasons for exclusion. It was published in ...
... Attention-deficit/hyperactivity disorder (ADHD), a state of serious impairments in ... many labels for one of the most prevalent conditions ... partly persists into adulthood. ADHD is conservatively estimated to ... 1998), but more permissive criteria yield estimates of up ...
Cached Medicine News:Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 2Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 3Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 4Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 5Health News:Study: Modafinil is effective in treating excessive sleepiness 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 3Health News:1 in 5 bariatric surgery candidates not psychologically cleared for surgery 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3
(Date:8/22/2014)... 2014  As the Medical Affairs, role has become ... this area are exploring methods to develop strong capabilities ... Consortium at Best Practices, LLC is designed to give ... the key challenges they face. The consortium will provide ... virtual roundtable discussions where leaders discuss key findings from ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... Aug. 22, 2014  Research presented at the 29 th ... developed by Hera Therapeutics Inc. combats three types of human ... cervical cancer. When tested in several cultured human ... HPV-11 cells, according to Louise T. Chow , Ph.D. ... at the Seattle conference. The National ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... KALAMAZOO, Mich., Sept. 9 Global Pharmaceutical Services ... the worldwide pharmaceutical and biotechnology industry announces a new clinical ... has entered into an exclusive partnership with Abridge Clinical Research ... India. "We are delighted in working with such an experienced ...
... , IRVINE, Calif., Sept. 8 ... U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ... ocular itching associated with allergic conjunctivitis in patients two years of ... new, safe and effective way to treat the itching caused by ...
Cached Medicine Technology:Life Sciences Company Opens Clinical Trial Bridge to India 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 3ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 4ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 5
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... BTA stat Test is an ... qualitative detection of bladder tumor ... with bladder cancer. This test ... aid in the management of ...
... TheraTears Liquid Gel is a thicker version ... or for those who need a longer-lasting ... Liquid Gel is so long-lasting, it is ... preserved gels, there never needs to be ...
Medicine Products: